US Market Report for Virtual Colonoscopy 2017 - MedCore
Some of the major factors driving units down are an unfavorable reimbursement structure and strong lobbying against using colonography as one of the key colon cancer screening methods. Most of sales have occurred in the period of 2004 and 2009 when colongraphy was gaining traction. However, since 2009 the market started to rapidly decline. As of 2016, colonography is only reimbursable by CMS under certain conditions (such as failed colonoscopy), and could be reimbursed under normal conditions in 21 states. Still, the official status of virtual colonoscopy has not been established within CMS. Many private insurance companies cover colonography. Overall, the market is expected to decline at an annual mid-single digit rate. One positive factor that might help counter unit erosion is a relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States, the market might turn its attention back to colonography.
The U.S. market for virtual colonoscopy is defined in this report as virtual colonoscopy software installed on workstations and servers for CT and MRI scanners. The value of the total U.S. market for colonoscopy software decreased in 2016. The negative trend is expected throughout the forecast period and will be driven by the drop in the units sales with slightly positive addition from the ASP. The majority of virtual colonoscopy software units are sold as part of the total software package for workstations to hospitals and outpatients facilities alike. Only a small portion of units are sold as a standalone solution. For the purpose of this report the ASP was calculated based on the price of virtual colonoscopy software as part of the software bundle.